Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Cellular Cardiomyoplasty For Myocardial Infarction: a 2014 Evidence-based Update

ACTA MEDICA INDONESIANA · Vol. 46 No. 2 (2016)

ISSN
2338-2732, 0125-9326
Terbit
2016-05-16
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Myocardial infarction is one of the main cause of mortality in many countries. Therefore, an effective therapy for myocardial infarction is required. Reperfusion and other conventional therapy have been the mainstay therapy for myocardial infarction. However, many patients remain refractory to this therapy. Cellular cardiomyoplasty is considered a novel therapy, in which stem cells are used for cardiac repair. Stem cells are potential therapeutic approach that could be the ultimate solution for salvaging damaged cardiomyocyte. Based on current studies, stem cells are a promising therapeutic approach for myocardial infarction. However, some challenges need to be answered by future studies before this novel therapy can be widely applied. As we advance our understanding, all questions behind stem cell therapy would finally be revealed, and eventually provide the ultimate solution for ischaemic cardiac repair. This paper provide an overview of the latest progress in stem cell therapy for myocardial infarction. Key words: stem cells, cellular cardiomyoplasty, myocardial infarction

Jaringan kolaborasi para penulis

29 penulis · 122 tautan kepenulisan bersama · 1 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Australian National University
  • Universitas Esa Unggul
  • Hasanuddin University
  • Padjadjaran University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Militcyano Samuel SapuletteAustralian National University3
Fikar AdiaksaAfiliasi tidak diketahui1
Donny HardiawanAfiliasi tidak diketahui1
Muhammad Faishal Akbar DwiputraAfiliasi tidak diketahui1
Maman SetiawanAfiliasi tidak diketahui1
Bayu KharismaAfiliasi tidak diketahui1
Bayu Rizky PratamaAfiliasi tidak diketahui1
Aurelia Puteri ArfitaAfiliasi tidak diketahui1
Iswadi IswadiUniversitas Esa Unggul1
Muhammad SayuthiAfiliasi tidak diketahui1
Ardian SaputraHasanuddin University1
Aru W SudoyoAfiliasi tidak diketahui1
Idrus AlwiAfiliasi tidak diketahui1
Cosphiadi IrawanAfiliasi tidak diketahui1
Djumhana AtmakusumahAfiliasi tidak diketahui1
Agus KosasihAfiliasi tidak diketahui1
Auda AzizAfiliasi tidak diketahui1
Abdulmuthalib AbdulmuthalibAfiliasi tidak diketahui1
Lyana LyanaAfiliasi tidak diketahui1
Sri InggrianiAfiliasi tidak diketahui1
Merry WinteryAfiliasi tidak diketahui1
Linda LisonAfiliasi tidak diketahui1
Ary H ReksodiputroAfiliasi tidak diketahui1
Ummi Ulfah MadinaAfiliasi tidak diketahui1
Cosmas Rinaldi A LesmanaAfiliasi tidak diketahui1
Nury EffendiPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Cellular Cardiomyoplasty For Myocardial Infarction: a 2014 Evidence-based Update</dc:title>
	<dc:creator>Nursalim, Alvin</dc:creator>
	<dc:creator>Katili, Puspita A</dc:creator>
	<dc:creator>Santoso, Teguh</dc:creator>
	<dc:description xml:lang="en-US">Myocardial infarction is one of the main cause of mortality in many countries. Therefore, an effective therapy for myocardial infarction is required. Reperfusion and other conventional therapy have been the mainstay therapy for myocardial infarction. However, many patients remain refractory to this therapy. Cellular cardiomyoplasty is considered a novel therapy, in which stem cells are used for cardiac repair. Stem cells are potential therapeutic approach that could be the ultimate solution for salvaging damaged cardiomyocyte. Based on current studies, stem cells are a promising therapeutic approach for myocardial infarction. However, some challenges need to be answered by future studies before this novel therapy can be widely applied. As we advance our understanding, all questions behind stem cell therapy would finally be revealed, and eventually provide the ultimate solution for ischaemic cardiac repair. This paper provide an overview of the latest progress in stem cell therapy for myocardial infarction. Key words: stem cells, cellular cardiomyoplasty, myocardial infarction</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2016-05-16</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/83</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 46 No. 2 (2014)</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/83/79</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Indonesian Journal of internal Medicine</dc:rights>
</oai_dc:dc>